Table 1.
Tac/Sir | Tac/Sir/Mtx | ||||
---|---|---|---|---|---|
N | % | N | % | p-value | |
Total | 29 | 100 | 46 | 100 | |
Age | 0.80 | ||||
≥50 | 20 | 69 | 33 | 72 | |
< 50 | 9 | 31 | 13 | 28 | |
median (range) | 53 (29–64) | 55 (20–69) | |||
Sex | 0.25 | ||||
M | 17 | 59 | 33 | 72 | |
F | 12 | 41 | 13 | 28 | |
Patient-Donor Sex Matching | 0.64 | ||||
MF | 11 | 38 | 18 | 39 | |
MM | 6 | 21 | 15 | 32 | |
FF | 7 | 24 | 6 | 13 | |
FM | 5 | 17 | 7 | 15 | |
Prior Transplant | 0.98 | ||||
Yes | 10 | 34 | 16 | 35 | |
No | 19 | 66 | 30 | 65 | |
Diagnosis | - | ||||
AML | 6 | 21 | 14 | 30 | |
Anemia/Red Cell Disorder | - | - | 1 | 2 | |
CLL, SLL, PLL | 3 | 10 | 7 | 15 | |
CML | 3 | 10 | 2 | 4 | |
Hodgkin Disease | 5 | 17 | 4 | 44 | |
MDS | 1 | 3 | 8 | 17 | |
MM/Plasma Cell Disorder | 2 | 7 | 2 | 4 | |
MPD | - | - | 1 | 2 | |
NHL | 9 | 31 | 7 | 15 | |
Risk Status | 0.37 | ||||
High Risk | 12 | 41 | 11 | 24 | |
Low Risk* | 17 | 59 | 35 | 76 |
Low risk defined as acute leukemia in CR1, de-novo MDS-RA or RARS, or first chronic phase CML. All others were considered high risk.